Nexbiome Therapeutics

Calculating rank

USPTO Granted Patents = 3

EPO Patents = 2

Forward Citations = 0

Loading Chart...

5 inventors (with patents filed for the assignee):

Adrien Nivoliez (3 out of 4 patents)

Vincent Mazel (1 out of 1 patent)

Pierre Tchoreloff (1 out of 4 patents)

4. Claudia Thoral (1 out of 1 patent)

5. Virginie Busignies (1 out of 1 patent)

3 patents: Sort by Forward Citations

1. 12390489 - Use of thiosulfate to potentiate the anti-pathogenic effect of lactobacilli (2025-08-19),

2. 11730777 - Mucoadhesive sustained-release vaginal tablet (2023-08-22),

3. 11197899 - Compositions for treating candidiasis infections (2021-12-14),

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

3 Patents

#21 in Clermont-Ferrand

#4,039 in France

Clermont-Ferrand, France

Nexbiome Therapeutics

Forward Citations = 0

5 inventors:

Adrien Nivoliez (3 out of 4 patents)

Vincent Mazel (1 out of 1 patent)

Pierre Tchoreloff (1 out of 4 patents)

4. Claudia Thoral (1 out of 1 patent)

5. Virginie Busignies (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nexbiome Therapeutics. Retrieved from https://idiyas.com/company/nexbiome-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]